Herewith a brief issue, as pandemic news has been thin over a holiday weekend. No news briefs today but of course there’s a frippery. WHO tackles naming the variants The designations given to the viral variants are not friendly; the … Continue reading →
Items of recent pandemic news: Moderna’s vaccine works in those 12 to 17 years old; the political nature of college mandates to vaccinate returning students; and a new, fast-spreading variant out of India. Plus news briefs and a frippery. B.1.617.2 … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Four items of recent pandemic news: Pfizer applies for full FDA approval; Moderna’s booster testing; the CDC’s optimistic report; and what it means that the US is open to waiving vaccine patent rights. Plus news briefs and a frippery. Waiving … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Three items of pandemic news you may have missed recently: Watching the virus evolve variants in a single human; a damning report on Emergent’s vaccine manufacturing plant; and the dimming prospects for herd immunity. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: A study on transmission from the vaccinated; the South African variant can evade Pfizer; and the US government suggests pausing J&J vaccination. Plus news briefs and a frippery. FDA and … Continue reading →
Three items of pandemic news you may have missed recently: Canada is struggling; J&J is ordered to take over Emergent’s factory; and the mRNA vaccines appear safe and effective in pregnant women. Plus news briefs and a frippery. mRNA shots … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed recently: The latest installment in the ongoing AstraZeneca saga; how the immunosuppressed respond to mRNA vaccination; and Minnesota’s opening up of eligibility for shots. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed: Vitamin D levels vs. infection probability in Black people; variant viruses infecting animals; and the roller coaster that is AstraZeneca’s Phase III results announcement. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: Kids and Covid-19; enhanced lethality of the B.1.1.7 variant; and more on the pause in AstraZeneca shots as Europe investigates a rare condition. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: One instance in Oregon of a scary variant; quantifying the variants’ immune escape; and the new CDC guidelines. Plus news briefs and a frippery. A year Before we dive … Continue reading →
Herewith three items of pandemic news you may have missed recently: Controlling the message on vaccines of different efficacy; Johnson & Johnson’s day in the spotlight; and media jumping the gun on viral variant stories. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: A caution for those scheduling mammograms around the time of vaccination; sterilizing immunity from vaccines; and peptides for prevention and treatment. Plus news briefs and a frippery. Peptides Dr. … Continue reading →
